abstract |
The present invention relates generally to inhibition of the disordered activation of serine-threonine protein kinases, in particular of PKC, and to the use of tetracyclic terpenol as an anti-inflammatory, anticancerigenous and analgesic agonist, Star-8,24-dien-3-ol < / RTI > |